Abiopharma

🔍 Intrator Michael N (Director)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-04-21

Detailed Transactions and Holdings:

• Sold 10,036 shares of Class A Common Stock at $114.709 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,256,465.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 90,943 shares of Class A Common Stock at $115.5394 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,165,522.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 41,082 shares of Class A Common Stock at $116.36 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,124,440.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 28,841 shares of Class A Common Stock at $117.7049 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,095,599.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 22,403 shares of Class A Common Stock at $118.3686 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,073,196.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 6,045 shares of Class A Common Stock at $119.2925 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,067,151.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 650 shares of Class A Common Stock at $120.328 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,066,501.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Acquired 107,693 shares of Class A Common Stock (Direct)
  Date: 2026-04-21 | Code: C | equity_swap_involved: 0 | shares_owned_after: 107,693.00 | transaction_form_type: 4 | Footnotes: F9, F10
• Sold 5,404 shares of Class A Common Stock at $114.709 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 102,289.00 | transaction_form_type: 4 | Footnotes: F1, F11, F10
• Sold 48,970 shares of Class A Common Stock at $115.5394 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 53,319.00 | transaction_form_type: 4 | Footnotes: F1, F3, F10
• Sold 22,121 shares of Class A Common Stock at $116.36 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,198.00 | transaction_form_type: 4 | Footnotes: F1, F4, F10
• Sold 15,530 shares of Class A Common Stock at $117.7049 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 15,668.00 | transaction_form_type: 4 | Footnotes: F1, F5, F10
• Sold 12,063 shares of Class A Common Stock at $118.3685 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,605.00 | transaction_form_type: 4 | Footnotes: F1, F6, F10
• Sold 3,255 shares of Class A Common Stock at $119.2925 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 350.00 | transaction_form_type: 4 | Footnotes: F1, F7, F10
• Sold 350 shares of Class A Common Stock at $120.328 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F8, F10
• Sold 107,693 shares of Class B Common Stock (Derivative)
  Date: 2026-04-21 | Code: C | equity_swap_involved: 0 | shares_owned_after: 24,526,201.00 | transaction_form_type: 4 | Footnotes: F9, F9, F9, F9, F10
• Holds 21,867,489 shares of Class B Common Stock (Derivative)
  Date: 2026-04-21 | Code: H | shares_owned_after: 21,867,489.00 | Footnotes: F9, F9, F9
• Holds 136,947 shares of Class B Common Stock (Derivative)
  Date: 2026-04-21 | Code: H | shares_owned_after: 136,947.00 | Footnotes: F9, F9, F9, F12
• Holds 4,576,000 shares of Class B Common Stock (Derivative)
  Date: 2026-04-21 | Code: H | shares_owned_after: 4,576,000.00 | Footnotes: F9, F9, F9, F13
• Holds 2,290,320 shares of Class B Common Stock (Derivative)
  Date: 2026-04-21 | Code: H | shares_owned_after: 2,290,320.00 | Footnotes: F9, F9, F9, F14
• Holds 365,200 shares of Class B Common Stock (Derivative)
  Date: 2026-04-21 | Code: H | shares_owned_after: 365,200.00 | Footnotes: F9, F9, F9, F15

Footnotes:

• F1: The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.04 to $115.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.04 to $116.03, inclusive.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.04 to $117.03, inclusive.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.06 to $118.05, inclusive.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.06 to $119.04, inclusive.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.06 to $119.78, inclusive.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.18 to $120.58, inclusive.
• F9: Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
• F10: The reported securities are directly held by Omnadora Capital LLC ("Omnadora"). The reporting person is the sole manager of Omnadora's manager, Omnadora Management LLC. In such capacity, the reporting person may be deemed to beneficially own securities directly held by Omnadora. The reporting person disclaims beneficial ownership for purposes of Section 16 of the Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein.
• F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.04 to $115.03, inclusive.
• F12: The reported securities are directly held by the PMI 2024 F&F GRAT (the "PMI GRAT"). The reporting person is the sole beneficiary of the PMI GRAT and his spouse is trustee.
• F13: The reported securities are directly held by the Intrator Family GST-Exempt Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.
• F14: The reported securities are directly held by the Intrator Family Trust, of which the reporting person's spouse and children are the beneficiaries and his spouse serves as co-trustee.
• F15: The reported securities are directly held by the reporting person's spouse.